ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,182,000 | -45.4% | 5,742 | -68.2% | 0.00% | – |
| Q4 2016 | $36,947,000 | +4.5% | 18,068 | -10.5% | 0.00% | – |
| Q3 2016 | $35,347,000 | +117.9% | 20,198 | +112.9% | 0.00% | – |
| Q2 2016 | $16,219,000 | -83.7% | 9,485 | -81.9% | 0.00% | – |
| Q4 2015 | $99,450,000 | +4.0% | 52,342 | +4.6% | 0.00% | – |
| Q3 2015 | $95,609,000 | -65.2% | 50,057 | -15.4% | 0.00% | -100.0% |
| Q2 2015 | $274,391,000 | +1203.0% | 59,136 | +1127.1% | 0.00% | – |
| Q1 2015 | $21,059,000 | -93.8% | 4,819 | -76.4% | 0.00% | – |
| Q3 2014 | $339,298,000 | +11209.9% | 20,459 | +3895.9% | 0.00% | – |
| Q2 2014 | $3,000,000 | -99.0% | 512 | -99.1% | 0.00% | – |
| Q3 2013 | $286,725,000 | -53.4% | 54,407 | -32.0% | 0.00% | – |
| Q2 2013 | $615,900,000 | – | 79,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |